Biotech Stocks Surged: Moderna, BioNTech, Novavax

Biotech Stocks Surged: Moderna, BioNTech, Novavax

2021-11-08 • Atualizado

The biotech industry has always had a high potential to grow, but the pandemic has boosted this sector even more and as a result, attracted many new investors especially vaccine producers. Let’s go through the top stocks of the biotech industry.

Moderna

Moderna surged on the announcement that its Covid-19 vaccine was granted provisional registration by Australia's administration. Moderna is planning to supply as many as 25 million doses of its vaccine to the Australian government by 2022.

However, this company has a unique feature. It has joined one of the most credible stock indexes in the US – the S&P 500 index. It helped the stock to rise even more! Check our recent article to see what happened with Tesla when it joined S&P 500.

Moderna has almost reached the psychological mark of $500.00, but as it often happens, it has failed to cross such an important level on the first try. We can expect that sooner or later, it will break this resistance level and rally up further to the next round number of $550.00. Support levels are $400 and $350.00.

MRNADaily.png

Pfizer and BioNTech

BioNTech and Pfizer have recently published better than expected earnings results for the second quarter. The companies claimed they can produce up to 3 billion Covid-19 vaccines this year, with capacity increasing to 4 billion doses in 2022. Pfizer is getting closer to the $50.00 level, while BioNTech has reversed down from $463.00.

IMG_20210810_170511.679.jpg    IMG_20210810_170540.935.jpg

Novavax

Meanwhile, Novavax has gained from Barron’s article. It was written that the New York State Common Retirement Fund, the third-largest public pension in the US, has increased its stake in Novavax and other vaccine stocks. However, the vaccine maker claimed that it would delay submission of its Covid-19 vaccine to the Food and Drug Administration for emergency use authorization until the fourth quarter.

The breakout above the $240.00 resistance level will push the stock up to the high of April 27 at $260.00. After that, the stock price may jump to an all-time high near $320.00. Support levels are the 100- and 200-day moving averages of $190.00 and $170.00, respectively.   

NVAXDaily.png

Don't know how to trade stocks? Here are some simple steps.

  1. First of all, be sure you’ve downloaded FBS Trader app or Metatrader 5. FBS allows you to trade stocks only through this software.
  2. Open an account in FBS Trader or the MT5 account in your personal area.
  3. Start trading!

 

 

 

Semelhante

Últimas notícias

As expectativas dos mercados giram em torno do PCE dos EUA
As expectativas dos mercados giram em torno do PCE dos EUA

Todas as atenções estarão nos preços básicos do PCE (núcleo) dos EUA, que excluem alimentos e energia para o mês de março, com a expectativa de que os números venham abaixo do mês anterior, que registraram um aumento de 0,4%

Deposite com sistemas de pagamento locais

Aviso de coleta de dados

A FBS mantém registros de seus dados para operar este site. Ao pressionar o botão “Aceitar“, você concorda com nossa Política de Privacidade.

Ligue de volta

Um gerente ligará para você em breve.

Alterar número

Seu pedido foi aceito

Um gerente ligará para você em breve.

O próximo pedido de chamada para este número de telefone
estará disponível em

Se você tiver um problema urgente, por favor, fale conosco pelo
Chat ao vivo

Erro interno. Por favor, tente novamente mais tarde

Não perca seu tempo. Acompanhe o impacto das NFP no dólar dos EUA e ganhe dinheiro!

Você está usando uma versão antiga de seu navegador.

Atualize para a versão mais recente ou experimente outro navegador para uma experiência comercial mais segura, confortável e produtiva.

Safari Chrome Firefox Opera